Eupraxia Pharmaceuticals (EPRX.TO) Q3 2024 Earnings

7AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.59
-0.45
-0.31
-0.17

Details

Expected EPS
-0.232817457549534
Actual EPS
-0.17074398426
Surprise EPS
0.06
Surprise Percent
+26.66%

Description

Eupraxia Pharmaceuticals (EPRX.TO) has reported earnings of -0.17074398426 per share for Q3 2024.

0 Comments

Share your thoughts